{"id":"W2244529370","doi":"10.1200/jco.2009.27.15_suppl.1022","title":"Pertuzumab monotherapy following trastuzumab-based treatment: Activity and tolerability in patients with advanced HER2- positive breast cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Pertuzumab; Trastuzumab; Medicine; Tolerability; Internal medicine; Oncology; Metastatic breast cancer; Adverse effect; Breast cancer; Cancer; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005552282,0.000290393,0.0009166931,0.0001906864,0.0002477808,0.00044318,0.000155992,0.0003613299,0.0008427703],"category_scores_gemma":[0.0009411204,0.0001571849,0.0002824102,0.0003292597,0.0001349346,0.0002742608,0.0001741729,0.0005519476,0.0002475992],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004094324,"about_ca_system_score_gemma":0.0003618702,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003618756,"about_ca_topic_score_gemma":0.000769785,"domain_scores_codex":[0.9997903,0.00008827922,0.00002124879,0.0000333158,0.00003741604,0.00002951661],"domain_scores_gemma":[0.9996474,0.00007416338,0.00008299523,0.00001782678,0.00002996806,0.0001477339],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2793952,0.01601237,0.2386632,0.00111144,0.001257711,0.004252162,0.001207521,0.004006572,0.1036205,0.0001388106,0.003819757,0.3465148],"study_design_scores_gemma":[0.03099013,0.446297,0.4957248,0.0001081986,0.0008418753,0.004372695,0.0002333226,0.003177112,0.01005273,0.0001808145,0.007967223,0.00005406173],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983103,0.000995563,0.00006574501,0.00005650973,0.000008579866,0.00006482618,0.00006447295,0.00000829457,0.0004257064],"genre_scores_gemma":[0.9987615,0.0004039138,0.0001192051,0.0001329603,0.00003567662,0.00006775297,0.0002421235,0.000002872801,0.0002339184],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009166931,"threshold_uncertainty_score":0.002970695,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06210822724411943,"score_gpt":0.4834389207595168,"score_spread":0.4213306935153974,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}